Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Zylö’s Erectile Dysfunction Product Concept Wins Best Abstract Award
November 10, 2021 09:00 ET
|
Zylö Therapeutics
The product concept uses patent-pending Z-pods™ to sustainably—for over an hour—release nitric oxide GREENVILLE, SC, Nov. 10, 2021 (GLOBE NEWSWIRE) -- A novel nitric-oxide-releasing product concept...
Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 10, 2021 05:55 ET
|
Novan, Inc.
– Company executing on plans for three potential New Drug Application (NDA) filings in three years with the first submission targeted in Q3 2022 for lead program SB206 in molluscum contagiosum – –...
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
November 04, 2021 09:00 ET
|
Novan, Inc.
– Company highlights rationale of strategic pathway towards potential commercialization in collaboration with commercial solutions provider, Syneos Health – – Discusses recent progress and expected...
Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
November 03, 2021 09:00 ET
|
Novan, Inc.
DURHAM, N.C., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its third quarter 2021 financial results on Wednesday,...
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
November 02, 2021 08:30 ET
|
Novan, Inc.
– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology marketing, sales, sales management, digital marketing and managed care –– Company received...
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 20, 2021 09:00 ET
|
Novan, Inc.
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Novan Announces Strategic Priorities and Outlines Key Milestones
September 09, 2021 07:00 ET
|
Novan, Inc.
– Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum – – Late-stage...
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 09:00 ET
|
Novan, Inc.
DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Novan to Host Corporate Update Conference Call and Webcast on September 9, 2021
September 02, 2021 09:05 ET
|
Novan, Inc.
– Conference call with live audio webcast to be held on Thursday, September 9th at 8:30 a.m. ET – DURHAM, N.C., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:...
Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer
August 24, 2021 09:00 ET
|
Novan, Inc.
– Dr. Maeda-Chubachi, who served as Novan’s Senior Vice President, Medical has played a key role in the design and execution of the Company’s development programs – – Dr. Maeda-Chubachi was...